Mark Lackner

ZNTL

Mark Lackner serves as Chief Scientific Officer at Zentalis Pharmaceuticals, Inc. (ZNTL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$56.6K

Net Position

Net Seller

$56.6K

Companies Traded

ZNTL

Active Period

Feb 2024 – Feb 2025

3 total trades

Most Recent

Sell ZNTL

Feb 5, 2025 · $24.6K

Mark Lackner's Insider Trading at Zentalis Pharmaceuticals, Inc. (ZNTL)

Buys

0 · $0.00

Sells

3 · $56.6K

Total Shares Bought

Total Shares Sold

20,364

ZNTL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 5, 2025	Sell	14,368	$1.71	$24.6K	512,856
Jan 3, 2025	Sell	4,411	$3.12	$13.8K	191,317
Feb 5, 2024	Sell	1,585	$11.54	$18.3K	195,728

Related Insiders

Ingmar Bruns

officer: Chief Medical Officer

ZNTLSell · Feb 10, 2026

EASTLAND JULIA MARIE

director, officer: CEO & President

ZNTLSell · Feb 10, 2026

Vultaggio Vincent

PAO and PFO

ZNTLSell · Feb 10, 2026

WALTERS GROUP

10% Owner

ZNTLBuy · Dec 31, 2025

Scott Dunseth Myers

Director

ZNTLBuy · Apr 30, 2025

Explore More Insider Trading Data

ZNTL Insider Trading Activity

View all insider trades at Zentalis Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity